177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT03805594 · COMPLETED

Trial details

NCT number: NCT03805594
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma Prostate Adenocarcinoma Stage IV Prostate Cancer Stage IVA Prostate Cancer Stage IVB Prostate Cancer

Start date: 2019-05-10
Primary completion: 2024-01-10
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.